Chapter 15
Pharmacotherapy of Depression and Anxiety Disorders
نظرة عامة حول الاكتئاب
Depression is a common mental illness that manifests as major depression, persistent depressive disorder, and bipolar I and II disorders.
It can be ...
الأدوية المضادة للاكتئاب: نظرة عامة
Antidepressant drugs alleviate symptoms of depression by enhancing neurotransmission in the brain.
These agents are classified based on their chemical ...
الأدوية المضادة للاكتئاب: مضادات الاكتئاب ثلاثية الحلقات، ومثبطات استرداد السيروتونين الانتقائية، ومثبطات استرداد السيروتونين والنورأدرينالين
Tricyclic antidepressants, or TCAs, are first-generation antidepressants.
They block serotonin and norepinephrine reuptake transporters while inhibiting ...
الأدوية المضادة للاكتئاب: مثبطات أكسيداز أحادي الأمين والعوامل الأخرى
Monoamine oxidase inhibitors, or MAOIs, inhibit monoamine oxidase, increasing neurotransmitter levels.
Atypical antidepressants encompass drugs with ...
مرض باركنسون: نظرة عامة
Neurodegenerative disorders are progressive conditions characterized by the irreversible loss of neurons in specific brain regions.
The primary ...
مرض باركنسون: العلاج
Parkinson's Disease or PD is a neurodegenerative disorder characterized by an imbalance between cholinergic and reduced dopaminergic neurons.
The ...
نظرة عامة حول مرض الزهايمر
Alzheimer's disease, or AD, is a neurodegenerative disorder primarily affecting older adults, causing impaired memory and cognitive decline through ...
علاج مرض الزهايمر
The goal of Alzheimer's disease or AD pharmacotherapy is to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms, ...
Copyright © 2025 MyJoVE Corporation. All rights reserved